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ENJOY LONDON THIS SEPTEMBER
WITH CAMA
Time is running and very soon September will be with
us and the C A M A meeting in London will be starting,
continuing, and finishing. Don't miss this outstanding
opportunity to visit London, renew your certification as
an Aviation Medical Examiner by attending the FAA
Aviation Medicine Seminar which is included. By now
you should have received the color brochure showing
parts of the meeting such as travel arrangements, costs,
etc. Remember the Board of Trustees meeting on the
afternoon of Sunday, September 17th, followed that
evening by a grand reception with hot and cold hors
d'oeuvres and an open bar. Wednesday night will be the
medieval feast at the Beefeaters (walking distance).
Friday night will be the final banquet at the hotel and
Saturday morning will be departure for home.

Monday, Tuesday and Thursday nights are open. If
you want to go to the theater, it will be necessary to get
tickets very soon. Two popular theater productions at
that time will be "Phantom of the Opera" and " L e s
Miserables". Our transportation arrangements with
British Airways will be flexible enough to permit extensions to visit longer in Britain, or to visit other
countries, either before or after the CAMA meeting. T h e
special airfare from the several U S A departure cities
would NOT permit shortening the trip by coming late or
leaving early. We have had inquiries about upgrading
airfare from Tourist to First Class and this IS possible,
but if credits from other airline travel clubs or plans are
to be used, this must be cleared with the other lines.
Mileage credits for this trip on British Airways will be
accepted by American Airlines, United Airlines, and
U.S. Air. Perhaps others will also accept the mileage
credits, but we cannot promise at this time.

The minimum information about all that is included
with this "package" failed to mention a luncheon on
Tuesday September 19th and another luncheon and
also a trip to a medical museum on Thursday, September 21st. After the opening ceremonies on Monday,
September 18th, most of that day's program will be
devoted to FAA forms and explanations for NEW AME's.
This might be time for others to go on tours, such as to
the Tower of London, just two blocks from the Tower
Thistle Hotel which is our Headquarters for the meeting,
or to Windsor Castle, and/or the Doll House, or any of
numerous short trips available.
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Welcome Aboard!
We welcome the following new members into the fellowship of CAMA.

Frank Anders, M.D.
P.O. Drawer 630
Ville Platte, LA 70586

Bill R. Fulk, M.D.
P.O. Box 1116
Du Quoin, IL 62832

Larry C. Sears, M.D.
302 S. Grand
Gainsville, T X 76240

Mark Anderson, M.D.
2390 Redwood Road
Salt Lake City, U T 84119

Robert J . Goldstone, M.D.
2929 University Dr.
Coral Springs, F L 33065

John L. Sessions, D.O.
1609 S . Margaret
Kirbyville, T X 75956

J . R. Becky, M.D.
6750 Stapleton Drive South
Denver, C O 80216

Thomas G. Johnson, M.D.
311 No. Fourth St.
Oakland, MD 21550

David N. Sim, M.D.
6014 Emerald St.
Boise, ID 83704

Daniel B. Bond, D.O.
290 E. 15th Ave.
Eugene, OR 97401

David B. Kessler, M.D.
7610 Carroll Ave.
Takoma Park, MD 20912

Robert L. Stokes, M.D.
3621 Belleview
Kansas City, MO 64111

Avrom S. Brown, D.O.
N.E. Medical Center, #15
Roosevelt Blvd. & Welch Rd.
Philadelphia, PA 19114

James D. Levy, M.D.
C M C , Inc.
16 S . Eutaw St.
Baltimore, MD 21201

Lars Tjensvoll, M.D.
Risalleen 6 B
N-0374 Oslo, Norway

J . R. Burgess, M.D.
560 North Park
Helena, MT 59601

Dr. S.Y. Merali
38 Godfrey Dr.
Cooper Cliff, Ont. POM 1N0
Canada

Glen M. Byers, M.D.
2850 Westside Dr., NW
Cleveland, T N 37311
Sam C. Carter, M.D.
1722 S. Carolina
Harlingen, T X 78550
Dr. William Chernenkoff
502 Queen St.
Saskatoon, Saskatchewan S 7 K 0M5
Canada
Leopold Delisle, A.M.C.
350 Brassard Blvd.
St-Paul de Joliette
Que. J 0 K 3E0, Canada
John F. Evans, M.D.
P.O. Box 21046
Wichita, K S 67208

Peter Overgaard, M.C.
Box 484
Lindstrom, MN 44045
Vincent S. Parziale, M.D.
3803 Spring St., #305
Racine, Wl 53405
Leo F. Rogers, M.D.
3118 Custer Drive
Lexington, K Y 40502
E.M. Sager, M.D.
7000 Cutler Ave., N.E., #W-8
Albuquerque, NM 87110
Glenn D. Schexnayder, M.D.
214 Clinic Dr.
Donaldsonville, LA 70346
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Kurt von Maur, M.D.
10653 Sudan
Kalamazoo, Ml 49002
John W. Wang, M.D.
Route 101-A
Amherst, NH 03031
Dr. Swan S. Ward
4500 Clearview Parkway
Metairie, LA 70006
William A. Weathers, M.D.
502 Cajon St.
Redlands, C A 92373
Paul T. Wehman, D.O.
Box 508
Council, ID 83612
Joseph R. Wilson, M.D.
1198 Kenly Ave.
Hagerstown, MD 21740

NEWS OF MEMBERS
Dr. Story Musgrave, C A M A Life Member and N A S A
Astronaut for 22 years, will make his third journey
into space this August. T h e mission, S T S - 3 3 , will be
on D I S C O V E R Y . Story deployed the first I U S / T D R S
satellite and performed the first shuttle spacewalk
during the maiden voyage of C h a l l e n g e r in April,
1983. His second flight, also on Challenger, and
designated S p a c e l a b #2, was in J u l y 1985, and involved the operation of an astronomical observatory
carried in the shuttle cargo bay.

•

•

•

•

•

•

•

•

After 30 years of service in Papua, New Guinea,
CAMA member Dr. J a m e s (Jim) Jacobi was recently
honored with a Knighthood by her Majesty, Queen
Elizabeth II in the New Year's Honours List. Henceforth, Dr. Jacobi should be addressed as: Dr. Sir
James Jacobi, Kt., O B E , M.D. B.S., Phc.

•

•

•

•

•

•

•

•

Dr. M. Y o u n g S t o k e s III was recently elected a
director of the Silver Anniversary Fraternity, an organization of people who have been flying for more than
25 years.
Astronaut Story Musgrave
•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

Dr. Robert L. Wick, J r . , C A M A Past President, w a s
recently elected C h a i r m a n of the Air Transport A s sociation Medical Panel, the industry organization for
the United States Air Carriers.

•

C A M A Past President, Dr. Robert S . Poole, is the
new American Airlines Area Medical Director for the
Eastern Division, headquartered in New York City.

•

•

•

•

•

•

•

• • • • •

«r *

Al and Harriett Carriere have just completed their
second decade of service, as Secretariat, to the Civil
Aviation Medical Association.

•

•

Dr. Milton Gordon, our man in J e r u s a l e m , s e n d s
Shalom from the Holy L a n d . At age 77 he is retiring
after 15 years as Civil Air Surgeon for the State of
Israel. Milt still lectures at the Flight Surgeon's S e m inar for the Israel Air Force, and is a member of the
Aviation Appeal Board. He looks forward to attending
the London meeting in September.

•

•

•

•

•

•

•

Representatives from 20 countries attended a R e g ional Civil Aviation Medicine Seminar held in B a n g kok, February 20-24 1989, and sponsored by I C A O .
T h e following C A M A members were present: Dr.
George T a k a h a s h i , Ottawa, C a n a d a ; Dr. Steve Blizzard, Nepean, Ontario, C a n a d a ; and Dr. Silvio Finkelstein, Montreal, Canada.
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HIDDEN HEART
DISEASE
James

by
A. Sbarbaro, M.D.,

often dismissed as musculoskeletal or p s y c h o s o matic. C l e a r l y , any young person with a typical
history of exertional chest pain deserves further
attention and possibly stress testing. However, in
many of these individuals symptoms are transient,
not thought to be important by the patient, and
therefore unreported.

F.A.C.C

Hypertrophic cardiomyopathy, when one e x c l u d e s
young individuals who die suddenly of coronary
atherosclerosis, accounts for the largest percentage
of young patients dying suddenly. T h i s c o n g e n i a l l y
inherited abnormality of cardiac muscle often disproportionately thickens the intraventricular septum,
although abnormal myocardial cells can be present
in other myocardial locations, or even diffusely.
Patients often present with fatigue, dyspnea, chest
pain, or s y n c o p e . Any of these complaints, especially
in a patient with a systolic ejection murmur, should
prompt further cardiovascular evaluation. Careful
auscultation, employing the valsalva maneuver, can
often help determine the etiology of a systolic murmur
in the young. Palpation of the PMI and carotid artery
impulse are often helpful in this assessment, with the
rapid rise in ventricular pressure and mid-systolic dip
in pressure (with obstruction) giving the characteristic double apicla or carotid impulse. E c h o c a r d i o graphy is invaluable in further studying these patients
and is recommended when the clinical suspicion of
hypertrophic cardiomyopathy with or without left
ventricular outflow tract obstruction is present. Treatment include beta blockers, calcium blockers, and in
rare cases, septal myectomy. However, while s y m p toms may be improved by these maneuvers, the
incidence of sudden death is not altered. Clearly
such individuals, if hypertrophic cardiomyopathy is
documented, should be prohibited from engaging in
extremely strenuous activity.

Many patients with c a r d i v a s c u l a r abnormalities
present with clear and unequivocal symptomatology.
Breathlessness, chest pain, palpitations, and syncope
provide valuable c l u e s in the s e a r c h for the underlying etiology of these cardiovascular complaints. However, in recent years attention has been focused on a
large group of patients with significant cardiac disease and no symptoms. Within this population are
many individuals destined to undergo sudden cardiac
death as the first manifestation of c a r d i a c disease. In
fact, it has been estimated that as many as 25% of the
approximately 600,000 people who die suddenly in
this country every y e a r of c a r d i a c disease have
sudden death as their first warning of a c a r d i a c
problem. Accordingly, this monograph will focus
attention on the most common forms of hidden heart
disease and methods which the practitioner may
utilize in screening the asymptomatic population for
these disorders.
I believe the easiest way to understand this c o m plex subject is to group patients into two large
categories of hidden heart disease, congenital
and
acquired. Congenital forms of hidden heart disease
include congenital abnormalities of the coronary
arteries, the various forms of hypertropic cardiomyopathy, Marfan's S y n d r o m e , the Wolff-Parkinson-White
Syndrome, and the Idiopathic Long Q T Syndrome.
Congenital abnormalities other than those of the
coronary arteries will not be d i s c u s s e d here as the
presentation of those entities is usually not silent.

Although patients with typical Marfan's Syndrome
are easily detected clinically, very often significant
abnormalities of the aortic root and aortic valve may
be present in patients without the typical physical
stigmata of this disorder. O n c e again if there is any
suggestion that Marfan's S y n d r o m e is present, an
echocardiogram is invaluable in the further evaluation
of the patient. T h e tragic case of Flo H y m a n , whose
sudden death on the volleyball court w a s a complication of Marfan's S y n d r o m e , serves to illustrate the
occasional lethality of this condition.

With regard to acquired forms of hidden heart
disease, we in e s s e n c e are dealing with coronary
artery disease and silent myocardial ischemia. S i n c e
it is estimated that silent myocardial ischemia may be
present in as many as one to two million Americans,
we will give considerable attention to this problem.
Coronary artery anomalies (the case of Pete Maravich is a recent reminder) can account for sudden
death in young people. Anomalies s u c h as a single
coronary artery, take off of the left main coronary
artery from the right coronary c u s p , and take off of a
coronary artery from the pulmonary artery are c o n ditions which can cause chronic silent myocardial
ischemia and sudden death. At autopsy, the heart of
Pete Maravich was large and fibrotic suggesting
multiple episodes of myocardial ischemia in the past.

Finally, the WPW and the Long QT Syndromes c a n
be responsible for hidden heart disease and sudden
death. Patients with atrioventricular bypass tracts
having very short refractory periods may be at risk of
sudden death when atrial fibrillation develops, since
the short refractory bypass tract may allow the
conduction of three to four hundred impulses to the
ventricle causing ventricular fibrillation. Obviously,

Detection of these individuals continues to be
difficult since chest pain in young active people is
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their physicians with multiple coronary risk factors
and not been stress tested. T h u s , cardiologists are
recommending stress testing for all individuals over
the age of 35 with two or more coronary risk factors
as outlined above. If the stress test is completely
within normal limits, further evaluation is not necessary. What, however, does one do with a stress test
which shows significant S T depression in the absence
of symptoms, and furthermore what is the appropriate
next step in patients with borderline or equivocal
studies?

resting electrocardiograms are done infrequently in
otherwise healthy individuals and this condition will
prove difficult to diagnose. If an E K G pattern c o n sistent with W P W or the Long Q T Syndrome is seen,
cardiovascular referral is recommended.
A great deal of emphasis in the cardiology literature in the last few years has been directed towards
the syndrome of Silent Myocardial Ischemia. It is
now clear that as many as 80% of all episodes of
myocardial ischemia are silent and not appreciated
by the patient. Whether this is due to defective neural
pathways, a critically small mass of ischemic myocardium not leading to sufficient stimulation of pain
fibers, or some as yet unrecognized factors is unclear,
but the fact that the syndrome exists and is clinically
important has now been verified in multiple studies.
Using objective techniques s u c h as myocardial perfusion imaging, regional wall motion studies, and the
measurement of lactat production by the myocardium,
it is now clear that significant and even life threatening myocardial ischemia may exist without symptomatology. Clearly in patients with known coronary
disease, silent ischemia is common. Fortunately this
almost always responds nicely to treatment with
either long acting nitrates, beta blockers, or c a l c i u m
antagonists.

It now appears that radionuclide testing either with
thalium 2 0 1 , or gated blood pool imaging with t e c h netium pyrophosphate is the next appropriate diagnostic step in the subgroup of patients with multiple
coronary risk factors and positive or equivocal stress
findings. Patients whose radionuclide studies are
positive should be referred for coronary angiography,
but if the nuclear studies are negative, risk factor
control and close clinical observation would be most
appropriate.
What about ambulatory electrocardiographic recording with S T segment monitoring in the management of s u c h patients? It is my feeling that this is
basically a research tool at present which has been
to be shown of value only in a s s e s s i n g patients with
known coronary disease. T h u s ambulatory holter
type recordings are not of particular value in the
screening of individuals for silent coronary disease
or for the management of the average patient with
this condition. T h i s I believe is true because the
ischemia detected in patients by ambulatory E K G
monitoring is almost always detected on exercise
stress testing. In fact, it is almost always the case that
the only patients who have frequent and prolonged
episodes of ischemia during ambulatory monitoring
have ischemia induced at low levels of exercise during
stress testing; patients with no ischemia changes
during e x e r c i s e or ischemia only at high levels of
exercise rarely have silent ischemia during ambulatory monitoring. T h u s the routine use of ambulatory
E K G monitoring to document the presence of myocardial ischemia in patients with chronic stable angina
provides little additional information beyond that
derived from stress testing.

How is the practitioner to evaluate the postulated
one to two million individuals in this country who are
completely asympromatic with silent i s c h e m i a ? I
believe that the most reasonable approach is one
which utilizes cardiac risk factors as a preliminary
screening technique for further evaluation. I have
listed below what I consider to be the major risk
factors for development of coronary disease in our
population, and I would recommend that any individual over the age 35 with two or more of these risk
factors undergo multistage exercise testing.

• Male S e x
• Family History of Premature Coronary Heart
Disease (Definite Ml or Sudden Death Before Age
55 in a Parent or Sibling)
• Cigarette Smoking
• Low H D L Cholesterol Concentration ( < 3 5 mg/dl)
• Diabetes Mellitus
• Hypertension
• Presence of Cerebrovascular or Peripheral Artery
Disease
• Sever Obesity (More T h a n 30% Overweight)

Nonetheless, we should not take ischemia lightly in
patients with coronary disease. Clearly, the presence
of ischemia is a negative prognostic factor in these
patients. Effective pharmacologic and revascularization strategies now exist to render all our patients
with silent or overt coronary disease ischemia free.

While this may appear to be a huge and costly
undertaking, it is clear to me that the state of the art
in cardiovascular medicine is clearly moving in this
direction as we begin to appreciate the magnitude of
the silent ischemia problem. In fact, there have been
several lawsuits filed by relatives of patients suffering
sudden c a r d i a c death who had previously visited

In summary, hidden heart disease continues to be
a clinical challenge. If symptoms suggestive of myocardial ischemia (such as chest pain or heaviness,
undue breathlessness with exercise, or any anginal
—5—

long acting nitrates, calcium blockers and beta blockers to minimize long term morbidity and mortality in
this condition.

equivalent type symptoms) are present then multistage exercise testing is appropriate. A s mentioned
above, patients over the age of 35 with two or more
coronary risk factors should undergo stress testing,
with nuclear studies either of the perfusion or gated
blood pool type reserved for those with positive or
equivocal studies. Echocardiography should be utilized in patients with histories and physical e x a m i n ations consistent with hypertrophic cardiomyopathy,
valvular heart disease or the Marfan's S y n d r o m e .
Cardiology and possibly electrophysiologic referral
is important in patients suspected of having WPW or
the Long Q T S y n d r o m e . Myocardial ischemia, if
detected, should be treated aggressively with aspirin,

* J a m e s A. Sbarbaro, M.D., F.A.C.C. received his
M.D. degree at the University of
Pennsylvania.
He is Clinical
Instructor
in Medicine
at the
University of Colorado Health Sciences
Center,
Denver, Colorado. A member of the American
College of Physicians,
a Fellow of the American
College of Cardiology, he is also a Diplomate in
Internal Medicine and Cardiovascular
Disease,
American Board of Internal
Medicine.

HONESTY, Are We Really
Totally honest?
health, no matter how unpleasant the results may be.
Once any person, and more especially a patient, learns
they have been given untrue information, they can
never again trust the person as totally and completely
as before. Initially, almost all of us tend to believe any
person with whom we come in contact until or unless
something is found untrue. Next we may overreact and
tend to distrust almost everyone. Such distrust may be
channeled toward a sex, an age group, a religious
group, an ethnic group, or others. Not that such is
justified, but we felt put upon or our feelings were hurt.
All of us are very familiar with the way our laws or rules
change. This makes us suspicious of our governmental
representatives and those of nations other than our
own. Peace and progress are NOT built on distrust.
Regardless of past experiences, we must become more
trusting and also more trustworthy and honest. As we
look ahead to meeting with our colleagues and members
from many nations, let us work together in honest
harmony.

Every one of us takes pride in being honest and
having a reputation as an honest person. We have more
respect for our 'honest' colleagues and associates and
our children. But is this 100%? Have you ever complimented someone on an accomplishment or a new
article of clothing just to avoid hurting someone's
feelings, even though you really did not think a compliment was deserved? Have you ever added or subtracted
a little from the actual when asked about your age or
height or weight or speed or car mileage? Surely most
of us have at some time or another given in to such
temptations with the rationalizations that it really didn't
matter. Compromise a little when "it wouldn't hurt
anyone or anything." But this is not true, for it hurts the
individual. Any misrepresentation can make the next a
little easier, so where do we draw the line? How many
parents have asked children to help watch for law
enforcement officers when driving a little faster than the
speed limit? After a few years these same parents fuss
at the same children when the child "drives a little too
fast." We need not go out of our way to be brutally blunt
hurting others, but sometimes it is really better to say
nothing. I often tell my patients and their families that I
will not hide the truth from them concerning their

M. Young Stokes III, M.D.
President, CAMA
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